Osteoarthritis

Feasibility and predictive value of proposed early endpoints for randomized controlled trials in knee osteoarthritis

Osteoarthritis CartilagePublished Retrospective cohort study

Authors' conclusion

Based on feasibility (sample size) and clinical relevance (association with subsequent TKR), we propose that the esKOA, CKOASO, and FNIH endpoints be prioritized for further consideration.

Study context

Population
Knees from the Osteoarthritis Initiative meeting typical randomized controlled trial (RCT) inclusion criteria, including pain and radiographic osteoarthritis (OA)knees, one per participant
Participants
1,350 knees
Exposure
Proposed early endpoints for knee OA RCTs compared for feasibility and association with subsequent total knee replacement (TKR)
Outcome
Cumulative incidence of each endpoint and sample size required for an RCT to detect HR 0.67 with 80% power
Follow-up
4 years
Methodological detailsOsteoarthritis Initiative data, sample size simulation for RCT (HR 0.67, 80% power)
  • Osteoarthritis Initiative data
  • Sample size simulation for RCT (HR 0.67, 80% power)

Main finding

As reported in the abstract

GroupValueSample size per arm
TKR4.3%3028
FNIH13.8%
End-stage knee OA (esKOA)34.4%
Composite Knee Osteoarthritis Symptom Outcome (CKOASO)63.6%229

Value

TKR4.3%
FNIH13.8%
End-stage knee OA (esKOA)34.4%
Composite Knee Osteoarthritis Symptom Outcome (CKOASO)63.6%

Sample size per arm

TKR3028
FNIH— not stated in the abstract
End-stage knee OA (esKOA)— not stated in the abstract
Composite Knee Osteoarthritis Symptom Outcome (CKOASO)229

Observational data: associations, not effects.

Further findings

OutcomeesKOACKOASOFNIH
RR of subsequent TKR after reaching endpoint · subsequent 5 years
RR5.74.32.6

Original publication

Feasibility and predictive value of proposed early endpoints for randomized controlled trials in knee osteoarthritis. Osteoarthritis Cartilage. Published 20 February 2026. doi:10.1016/j.joca.2026.02.001

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.